Chronic Kidney Disease

Understand chronic kidney disease with a specialist's guide on early detection , diagnostic criteria, risk factors, and evidence-based management strategies.

Given its often asymptomatic nature in early stages, delayed diagnosis is common, underscoring the need for heightened clinical vigilance and comprehensive risk assessment. This article reviews current understanding and evidence-based approaches to early detection and management of CKD, targeting clinicians engaged in primary and specialty care.
Screening for Chronic Kidney Disease

Importance of CKD screening and early detection CKD affects more than 35 million adults in the United States, and most are undiagnosed. CKD often develops without symptoms and is a common complication of diabetes and high blood pressure. Health care providers play a critical role in screening patients at risk for CKD and offering treatment early . Simple blood and urine tests can catch this ...
Early detection of chronic kidney disease involves identifying risk factors and implementing timely interventions to prevent progression and improve patient outcomes.

Early detection of chronic kidney disease
RATIONALE FOR EARLY DETECTION The rationale for testing asymptomatic people for chronic kidney disease (CKD) is that earlier detection might allow for the implementation of therapeutic interventions and avoidance of inappropriate exposure to nephrotoxic agents, both of which may slow the progression of CKD to end-stage kidney disease (ESKD) [7,8].
A simple and low cost blood and urine test can detect kidney disease . Earlier detection among those at risk would allow introduction of low-cost medical management strategies and patient education necessary to slow the progression of kidney disease , reduce the associated co-morbidities, and better prepare those who do progress to kidney failure ...

Perspectives on early detection of chronic kidney disease
Chronic kidney disease (CKD) is a growing global health burden, as measured by financial cost, mortality, morbidity, or other indicators.1 In 2017, the Global Burden of Disease (GBD) study found 697.5 million cases of CKD, indicating a global prevalence of 9.1%.2 CKD is currently the third-fastest growing cause of death worldwide and is expected to become the world's fifth-leading cause of ...
ISN-KDIGO CKD EARLY IDENTIFICATion & Intervention Toolkit Chronic kidney disease (CKD) causes substantial global morbidity and increases cardiovascular and all-cause mortality, so identifying and treating it at the earliest stages is a worldwide imperative. To this end, the ISN and KDIGO released a series of tools for CKD early identification and intervention aimed at kidney health ...

Early Identification and Screening for Chronic Kidney Disease
Screen with both uACR and eGFR Screen when patients have risk factors for CKD: type 2 diabetes, hypertension, age> 60, obesity, family history of kidney disease , history of acute kidney injury (AKI), history of tobacco use, social drivers (i.e.: poverty and/or food insecurity) CKD can be described as an accelerator of chronic disease 7.








Talking With Your Patients About Kidney Disease Identify & Evaluate Patients with Chronic Kidney Disease Urine and blood tests are used to detect and monitor kidney disease . Currently, the key markers used include abnormal urine albumin levels and a persistent reduction in the estimated glomerular filtration rate (eGFR).